Long-term Study of Epiduo in Patients With Moderate to Severe Acne
NCT01618773
·
clinicaltrials.gov ↗
COMPLETED
Status
6036
Enrollment
INDUSTRY
Sponsor class
Conditions
Acne Vulgaris
Interventions
DRUG:
0.1% adapalene / 2.5% benzoyl peroxide
Sponsor
Galderma Laboratorium GmbH